| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Feb 2026 | 11 Feb 2026 |
| Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve Un-Audited Financial Results for the Third Quarter and Nine Months ended on 31st December 2025. | ||
| Board Meeting | 13 Nov 2025 | 11 Nov 2025 |
| Quarterly Results-Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Un-audited Financial Results (Standalone) of the Company for the Quarter and Half year ended on 30th September, 2025, along with Limited Review Report of the Statutory Auditors thereon; UNAUDITED FINANCIAL RESULTS AS ON 30.09.2025 (As per BSE Announcement dated on: 13.11.2025) | ||
| Board Meeting | 30 Oct 2025 | 30 Oct 2025 |
| Outcome of Board Meeting dated Thursday 30th October, 2025 for : 1. Change of place of business where the books of accounts are maintained and ; 2. Change of name of the Company once the name is issued by MCA. | ||
| Board Meeting | 8 Sep 2025 | 8 Sep 2025 |
| Change of Object of the Company. | ||
| Board Meeting | 14 Aug 2025 | 11 Aug 2025 |
| Quarterly Results-Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Un-Audited Financial Results of the Company for the Quarter ended on 30th June, 2025. FINANCIAL RESULTS 30.06.2025 (As Per BSE Announcement Dated on: 14.08.2025) | ||
| Board Meeting | 7 Jul 2025 | 7 Jul 2025 |
| Outcome of Board Meeting dated 07th July 2025 Revised Outcome of the Board Meeting held on 07th July, 2025. (As Per BSE Announcement Dated on: 25.07.2025) | ||
| Board Meeting | 20 May 2025 | 15 May 2025 |
| Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve consideration & approval of Audited Financial Results. AUDITED FINANCIAL RESULTS 31.03.2025 (As Per BSE Announcement Dated on: 20/05/2025) | ||
| Board Meeting | 18 Feb 2025 | 13 Feb 2025 |
| GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/02/2025 inter alia to consider and approve proposal for sub- division/split of the equity shares of the Company in such manner as may be determined by the Board of Directors and subject to approval of the Shareholders and such authorities as may be required Outcome of the Board Meeting held on Tuesday 18th February, 2025 1. Approved Stock-split/sub-division of each equity share of the Company, having face value of Rs.10/- each, into 1 (One) equity share of face value Re. 1/- each, subject to approval of the shareholders of the Company and other statutory/regulatory authorities, as may be required. In this respect, the record shall be decided by the Board separately which shall be intimated to Exchange in the due course. 2. Approved substitution / alteration in the Main Object Clauses of the Memorandum of Association of the Company subject to approval of the shareholders of the Company in the ensuing Annual General Meeting/Extra Ordinary General Meeting of the Company. 3. Approved the proposed change in name of the Company from Gujarat Inject (Kerala) Limited to Shrikara Enterprise Limited or any other name as may be available and approved by Ministry of Corporate Affairs and consequential alteration in Memorandum of Association and Articles of Association of the Company to give effect to the change of name of the Company, subject to the approval of shareholders of the Company by way of special resolution and other concerned authorities (As Per BSE Announcement Dated on 18.02.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
